Sep 17, 2020

Left Ventricular Assist Device For Advanced Heart Failure

Information about the Medtronic HeartWare™ HVAD™ System, which is a left ventricular assist device (LVAD) that helps the heart pump and increases the amount of blood that circulates through the body.

The following media kits are made available to provide reporters with background information on the range of Medtronic therapies and the conditions they treat.

 
Apr 8, 2019
New Data Show Encouraging Economic Outcomes for Medtronic HeartWare(TM) HVAD(TM) System
Positive HVAD LATERALTM Study Results Also Now Published in The Journal of Heart and Lung Transplantation

DUBLIN and ORLANDO, Fla. - April 8, 2019 - Medtronic plc (NYSE:MDT) today announced data showing promising economic outcomes for the Medtronic HeartWare(TM) HVAD(TM) System after analyzing...
 
Apr 5, 2019
Medtronic HeartWare(TM) HVAD(TM) System Demonstrates Reduction in Total Strokes, Disabling Strokes and Stroke-Related Mortality with Blood Pressure Management
Company Has Initiated a Post-Approval Study of Heart Failure Management Best Practices to Further Demonstrate Improved Patient Outcomes

DUBLIN and ORLANDO, Fla. - April 5, 2019 - Medtronic plc (NYSE:MDT) today announced the results of an analysis on the impact of stroke severity in patients receiving its HeartWare(TM) HVAD(TM)...
 
Jul 11, 2018
Medtronic Receives FDA Approval for Less-Invasive Heart Pump Implant Procedure
(GLOBE NEWSWIRE via COMTEX) --HeartWare(TM) HVAD(TM) System Only LVAD Approved for Implant via Thoracotomy or Median Sternotomy

DUBLIN - July 11, 2018 - Medtronic plc (NYSE: MDT) has received United States Food and Drug Administration (FDA) approval for a less-invasive implant approach of its HVAD(TM) System, a left...
 
Sep 27, 2017
Medtronic HeartWare(TM) HVAD(TM) System Approved for Destination Therapy
Patients with End-Stage Heart Failure Now Have New Options for Care

DUBLIN - September 27, 2017 - Medtronic plc (NYSE: MDT) has received U.S. Food and Drug Administration (FDA) approval for its HeartWare(TM) HVAD(TM) System as a destination therapy for patients...